Themes
Morph
Quartz
Sketchy

Albert Hoffman Discovered the Hallucinogenic Effect of LSD

Albert Hoffman was a Swiss chemist from January 11, 1906 to April 29, 2008.


Albert Hoffman Discovered the Hallucinogenic Effect of LSD

In an alternate history, Albert Hoffman discovered the hallucinogenic effect of LSD through a different method, which led to a series of unexpected consequences and developments in the world of psychedelic substances.

1938

Instead of accidentally ingesting LSD-25, Albert Hoffman discovers the hallucinogenic effect of a different compound called DMT (N,N-Dimethyltryptamine).

1943

Hoffman publishes his findings on the hallucinogenic properties of DMT, detailing his personal experiences and the potential therapeutic benefits of the substance.

1950s

The pharmaceutical industry takes an interest in DMT, leading to extensive research and clinical trials on its potential medical applications.

1962

The United States Food and Drug Administration (FDA) approves DMT as a prescription medication for the treatment of mental health disorders, such as depression and anxiety.

1965

The counterculture movement of the 1960s embraces DMT as a tool for spiritual exploration and personal growth, leading to a surge in popularity among artists, musicians, and intellectuals.

1970

The Controlled Substances Act is passed in the United States, categorizing DMT as a Schedule I substance due to its hallucinogenic properties. Its use becomes illegal, severely limiting scientific research and medical applications.

1980s

Underground laboratories and clandestine chemists continue to produce DMT, leading to a thriving black market for the substance.

1990s

Scientific discoveries reveal the potential of DMT in treating addiction and post-traumatic stress disorder (PTSD). Advocacy groups and researchers push for the reclassification of DMT to allow controlled medical use.

2005

Several European countries, including Switzerland and the Netherlands, decriminalize DMT and establish regulatory frameworks for its controlled use in therapeutic settings.

2025

The United States, influenced by growing evidence and shifting public opinion, initiates the process of reevaluating the legal status of DMT. Clinical trials and research on the therapeutic benefits expand, with promising results in treating various mental health conditions.

2035

DMT-assisted therapy becomes an accepted and regulated treatment option in many countries, with specialized clinics offering guided sessions for patients seeking profound spiritual experiences or relief from mental health disorders.


comment